Clinical Journal of HIV & AIDS

Home / Browse Journals & Books / Clinical Journal of HIV & AIDS / Archive / Volume 6, Issue 1

Table of Content: Volume 6, Issue 1

Select All | |

Research Article Pages 89-97

Enhanced Adherence Counselling, Support Groups and Viral Load Suppression amongst Adolescents in a Tertiary Health Care Facility in Cameroon

Authors: Agbornkwai Nyenty Agbor, Andre Izacar Gael Bita, Amatagana Mabouna Stephane, Ismaila Esa, Ajong Brian Ngongheh, Ateh Stanislas Ketum, Akateh Derek, Xavier Tchetnya, Djomo Nzaddi Audrey Raissa and Grace Tadzong-Awasum

Abstract: Globally, HIV viral load suppression rate which is an indirect measure of the efficacy of antiretroviral (ART) medication is 47% and 52% in Africa. In Cameroon, the viral load (VL) suppression rate is 44.7% and poor adherence is widely documented as being responsible for the large gap in VL Suppression. Enhanced adherence counselling (EAC) sessions, and enrolment and participation in support groups are specific interventions to improve ART adherence and improve viral load suppression.

| | |

Case Report Pages 85-88

A Fitting Warning an Atypical Cause of First Seizure Event

Authors: Yu Feng Shi and Sameer Malik

Abstract: Human Immunodeficiency Virus (HIV) has caused one of the greatest global pandemics in recent times and presents with a myriad of clinical manifestations due to its complex pathogenesis. Despite this, there is significant under-detection and delay in diagnosis. HIV also has significant neurological presentations, including seizures, which this case illustrates, as an atypical first presentation of HIV.

| | |

Research Article Pages 76-84

Assessment of Tenofovir-Induced Nephrotoxicity Development and Recovery in HIV Patients on TDF Based Regimens at Kenyatta National Hospital Comprehensive Care Clinic

Authors: Walter Odongo Owako

Abstract: TDF containing HAART is currently the most approved global HIV first-line treatment. Despite its accessibility as a mixture single-tablet regimen for once daily dosing, favorable safety profile and resistance, and effective antiviral activity, it is associated with renal impairment among patients with concurrent use of protease inhibitors and those with advanced HIV virus.

| | |

Publish with Scholars.Direct

Track your Manuscript Status

(Please write to editorialoffice@scholars.direct in case of any technical error)